You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (2) |
Back to Search
EFFECTS OF USAGE TREND WITH MEPM AND PIPC/TAZ ON SUSCEPTIBILITY RATE OF PSEUDOMONAS AERUGINOSA
- At: AbuDhabi (United Arab Emirates) (2019)
- Type: Poster
- Poster code: POS-HPS-087
- By: NAKATANI, Megumi (SAITAMA hospital, pharmacist, Japan)
- Co-author(s): Megumi Nakatani: pharmacist, SAITAMA hospital, Wako-shi, Suwa, Japan
Yuki Kimura: pharmacist, SAITAMA hospital, Wako-shi, Suwa, Japan
Tomoko Yufu: pharmacist, SAITAMA hospital, Wako-shi, Suwa, Japan - Abstract:
Background
There has been usage restriction of carbapenem antibiotic (CP) in Japan. Since one of the objectives was set to lower susceptibility rate of Pseudomonas aeruginosa against CP with AMR action plan in 2016, many medical facilities restricted the usage of CP. Thus, Piperacillin/Tazobactam (PIPC/TAZ) often tends to be selected as an.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026